AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Boston Scientific Corpora... (BSX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

105.36

1.82 (1.76%)

At close: Feb 05, 2025, 11:40 AM

undefined% (undefined)

Bid	105.25
Market Cap	155.28B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	1.21
PE Ratio (ttm)	87.07
Forward PE	n/a
Analyst	Buy

Ask	105.31
Volume	3,644,792
Avg. Volume (20D)	5,313,384
Open	102.94
Previous Close	103.54
Day's Range	102.44 - 107.17
52-Week Range	64.39 - 107.17
Beta	undefined

About BSX

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization th...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date May 19, 1992

Employees 48,000

Stock Exchange NYSE

Ticker Symbol BSX

Website https://www.bostonscientific.com

Analyst Forecast

According to 23 analyst ratings, the average rating for BSX stock is "Buy." The 12-month stock price forecast is $100, which is a decrease of -5.09% from the latest price.

Buy 91.30%

Hold 8.70%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Boston Scientific Corporation is scheduled to release its earnings on Feb 5, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

Just now New

Boston Scientific shares are trading higher after ... Unlock content with Pro Subscription

4 weeks ago

+4.3%

Boston Scientific shares are trading higher after the company announced it entered into a definitive deal to acquire Bold Medical.

News

1 day ago · zacks.com

Can These 5 MedTech Stocks Hit Earnings Targets This Season?

Here is a sneak peek into how five MedTech stocks, BSX, HOLX, TECH, STE and ALGN, are expected to fare in their quarterly results, slated to be released tomorrow.

5 days ago · zacks.com

PBH vs. BSX: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents invest...

5 days ago · zacks.com

What Analyst Projections for Key Metrics Reveal About Boston Scientific (BSX) Q4 Earnings

Evaluate the expected performance of Boston Scientific (BSX) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its ke...

6 days ago · zacks.com

Will Cheaper AI Models Like DeepSeek Become a Boon? 3 Stocks to Watch

As costs related to AI models may come down, as is evident from the cheaper DeepSeek model from China, MedTech companies developing AI-based solutions like SYK, BSX and TEM are likely to gain.

1 week ago · zacks.com

BSX Pre-Q4 Earnings: To Buy or Not to Buy Boston Scientific Stock Now?

Boston Scientific is expected to have registered strong growth in the Asia Pacific in the fourth quarter, led by strength in China and Japan.

1 week ago · zacks.com

Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy?

Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago · zacks.com

Boston Scientific (BSX) Increases Despite Market Slip: Here's What You Need to Know

In the closing of the recent trading day, Boston Scientific (BSX) stood at $102.27, denoting a +0.32% change from the preceding trading day.

2 weeks ago · zacks.com

BSX Stock Rises on Positive Data Announcement at the AF Symposium

Boston Scientific announces favorable study data for its FARAPULSE PFA system and WATCHMAN FLX device at the AF Symposium 2025.

2 weeks ago · zacks.com

Boston Scientific (BSX) Increases Yet Falls Behind Market: What Investors Need to Know

Boston Scientific (BSX) closed the most recent trading day at $98.66, moving +0.5% from the previous trading session.

3 weeks ago · zacks.com

PBH or BSX: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two stocks offers va...

3 weeks ago · zacks.com

M&A Synergies Drive BSX: Is it Worth Buying the Stock Now?

Boston Scientific's recent acquisitions have added numerous products with immense potential.

2 weeks ago · fxempire.com

Boston Scientific Jumps Ahead of Earnings

Boston Scientific Corporation (BSX) shares rise on acquisitions – earnings due in early February.

3 weeks ago · zacks.com

Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors

The latest trading day saw Boston Scientific (BSX) settling at $94.61, representing a -0.28% change from its previous close.

3 weeks ago · youtube.com

Stocks on the move: Delta, Constellation Energy, Wynn, Sweetgreen and Boston Scientific

The Investment Committee discuss some stocks on the move today.

3 weeks ago · zacks.com

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

3 weeks ago · zacks.com

BSX Stock Rises Following Bolt Medical Acquisition Deal Announcement

Boston Scientific inks a new agreement to acquire Bolt Medical, developer of Bolt IVL, for approximately $443 million.

4 weeks ago · youtube.com

Final Trades: Apollo, UnitedHealth, Boston Scientific and the IYF

The Investment Committee give you their top stocks to watch for the second half.

4 weeks ago · benzinga.com

Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal

On Wednesday, Boston Scientific Corporation BSX agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for coronary and peripheral arte...

4 weeks ago · zacks.com

Boston Scientific Corporation (BSX) Hits Fresh High: Is There Still Room to Run?

Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

4 weeks ago · zacks.com

Endoscopy Sales Growth to Support BSX Stock Amid Fierce Competition

Boston Scientific successfully continues its expansion of operations across different geographies outside the United States.

Load More News